Aytu Biopharma AYTU
NASDAQ AYTU
$2.00 +0.03 (+1.79%)
As of: Oct 22, 2026 · 1:34 PM EDT

Aytu Biopharma (AYTU) Short-Term Debt repayments (2021 - 2022)

Updated

Aytu Biopharma's Short-Term Debt repayments came in at $30.52 million for fiscal Q1 2023 (quarter ended Sep 30, 2022), down 33.1% from $45.63 million a year earlier and down 22.4% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Short-Term Debt repayments (2021 - 2022) Analysis & Trends

Over the trailing twelve months to Sep 30, 2022, Aytu Biopharma reported Short-Term Debt repayments of $163.5 million; for FY2022 (ended Jun 30, 2022), it was $156.36 million, up 189.7% from FY2021.

  • Going back by fiscal year, Short-Term Debt repayments was $53.98 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn -
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn 6.63 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn -
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn -
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn -
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn -
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn -
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn -
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn -
10 Aytu Biopharma 24.58 Mn -91.10 Mn 10.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 30.52 Mn
Jun 30, 2022 39.35 Mn
Sep 30, 2021 45.63 Mn
Jun 30, 2021 48.01 Mn
API Access

Aytu Biopharma Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=AYTU&period=max&api_key=YOUR_API_KEY